云起资本投资管理公司和STAAR Surgical 5.1%股东宣布反对公司提议出售给Alcon，具体条款于2025年8月5日宣布

2025-09-22 18:07

Issues Open Letter to Shareholders Outlining Its Belief that the Proposed Merger Materially Undervalues STAAR
Contends that STAAR's Board Failed In Its Responsibilities by Not Running a Thorough Process and Relying on Undue Skepticism about the Company's Prospects
Shareholders Deserve Fair Value for the Company